Asthma: Clinical Trials

32 trials for Asthma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

32 terminated. 32 Phase 1, 9 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 132Terminated 32
Phase 29Terminated 9

Follow Asthma: new trials by email Literature Review of Asthma trials Research Report on Asthma

Trials (filtered) newest first · largest first

All 32 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Safety and Efficacy of Briquilimab in Participants With Allergic Asthma
Briquilimab, Placebo Comparator - Allergic Asthma
Phase 1TerminatedJasper Therapeutics, Inc.172024-11-262025-09-16
Study of ARO-MUC5AC in Healthy Subjects and Patients With Muco-Obstructive Lung Disease
ARO-MUC5AC, Placebo - Asthma, Chronic Obstructive Pulmonary Disease
Phase 1 / Phase 2TerminatedArrowhead Pharmaceuticals782022-06-272026-09-14
Mechanisms of Interferon Gamma-primed Mesenchymal Stromal Cells (MSCs) for Moderate-to-severe Persistent Asthma
Albuterol Sulfate, Interferon gamma-primed mesenchymal stromal cells (MSCs), Prednisone - Asthma
Phase 1TerminatedEmory University12022-03-162025-06-03
Safety and Efficacy Active Drug vs. Placebo in Subjects With Asthma
Zavegepant, Placebo - Asthma
Phase 1TerminatedPfizer452021-10-182024-07-19
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
LQ036, Matching Placebo - Asthma
Phase 1TerminatedSyneos Health402021-09-062023-04-13
A Trial of SHR-1703 in Healthy Subjects
SHR-1703, Placebo - Asthma
Phase 1TerminatedAtridia Pty Ltd.12021-06-142021-12-01
Evaluation of AZD8154 Concentrations in Blood
AZD8154 nebuliser, AZD8154 Monodose DPI presented in capsules, AZD8154 Placebo Monodose DPI presented in capsules - Asthma
Phase 1TerminatedAstraZeneca102020-07-172021-08-24
A Study of MRx-4DP0004 in Asthma
MRx-4DP0004, Placebo - Asthma
Phase 1Terminated4D pharma plc342019-07-042024-04-17
Phosphodiesterase 4 Inhibitor, Roflumilast, and the Effects of Inhibition in Severe Asthma
Roflumilast, Placebo - Asthma
Phase 1TerminatedUniversity of California, Davis52019-01-212023-10-24
Lung Deposition of TRIMBOW® pMDI in Healthy Volunteers, Asthmatic and COPD Patients
Beclometasone dipropionate Formoterol Fumarate Glycopyrronium Bromide - Chronic Obstructive Pulmonary Disease, Asthma
Phase 1TerminatedChiesi Farmaceutici S.p.A.192019-01-142022-05-06
Trial of Tauroursodeoxycholic Acid (TUDCA) in Asthma
Tauroursodeoxycholic Acid - Asthma
Phase 1TerminatedUniversity of Vermont112019-01-102019-09-16
Allogeneic Human Cells (hMSC) Via Intravenous Delivery in Patients With Mild Asthma
hMSCs - Asthma
Phase 1TerminatedMarilyn Glassberg32017-06-222020-05-21
A Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of AZD9898
AZD9898, Matching Placebo - Asthma
Phase 1TerminatedAstraZeneca342017-05-102018-01-17
Safety, Tolerability and Pharmacokinetics of Oral Doses of RP3128 of Rhizen Pharmaceuticals
RP3128, Placebo - Healthy Volunteers, Asthma
Phase 1 / Phase 2TerminatedRhizen Pharmaceuticals SA572016-11-032019-10-04
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of RV6153
RV6153 single dose, RV6153 matching placebo single dose, RV6153 14 day repeat dose - Asthma, Healthy Volunteers
Phase 1TerminatedRespivert Ltd552015-07-012016-03-04
Study to Examine the Cytokine Levels, Gene Expression and Safety of a Single Nasal Dose of JNJ-43260295, in Healthy Participants, and Atopic Participants With Mild to Mild-Persistent Asthma
JNJ-43260295, Placebo, Nasal Allergen Challenge - Healthy, Asthma
Phase 1TerminatedJanssen Research & Development, LLC172014-10-012016-03-23
Safety and Feasibility Study of Intranasal Mesenchymal Trophic Factor (MTF) for Treatment of Asthma
Trophic factors from umbilical cord mesenchymal stem cells - Asthma
Phase 1 / Phase 2TerminatedTranslational Biosciences202014-07-012026-10-01
Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma
ASM-024 - Asthma
Phase 1 / Phase 2TerminatedAsmacure Ltée552013-03-012015-02-10
Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults
Arm T Epinephrine Inhalation Aerosol HFA, 125 mcg, 1 inhalation, Arm C-Epinephrine Inhalation Aerosol CFC - Asthma
Phase 1 / Phase 2TerminatedAmphastar Pharmaceuticals, Inc.212012-11-012016-03-17
AMG 761 in Adults With Asthma
AMG 761, Placebo - Asthma
Phase 1TerminatedAmgen72011-12-012014-04-21

Showing 20 of 32. Sign in to see all of them.

Narrower conditions

Hypersensitivity (3)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Bronchial Diseases (1)  ·  Chronic Disease (1)  ·  Dyspnea (1)  ·  Gastroesophageal Reflux (1)  ·  Hyperinsulinism (1)  ·  Hypersensitivity, Immediate (1)  ·  Immune System Diseases (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Motor Activity (1)  ·  Respiratory Hypersensitivity (1)  ·  Respiratory Sounds (1)

Broader conditions

Bronchial Diseases (31)  ·  Hypersensitivity, Immediate (31)  ·  Immune System Diseases (31)  ·  Lung Diseases (31)  ·  Lung Diseases, Obstructive (31)  ·  Respiratory Hypersensitivity (31)  ·  Respiratory Tract Diseases (31)  ·  Hypersensitivity (29)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Disease Attributes (3)  ·  Pathologic Processes (3)  ·  Chronic Disease (2)  ·  Behavior (1)  ·  Deglutition Disorders (1)  ·  Digestive System Diseases (1)

Interventions

Epinephrine (2)  ·  Prednisolone (2)  ·  ASM-024 (1)  ·  Albuterol (1)  ·  Antigens, Dermatophagoides (1)  ·  BASS2 protein, Arabidopsis (1)  ·  Bronchoscopy (1)  ·  Capsules (1)  ·  Esomeprazole (1)  ·  Interferon-gamma (1)  ·  Lipopolysaccharides (1)  ·  Magnetic Resonance Imaging (1)  ·  Phenol (1)  ·  Prednisone (1)  ·  RP3128 (1)

Sponsors

GlaxoSmithKline (3)  ·  Amphastar Pharmaceuticals, Inc. (2)  ·  AstraZeneca (2)  ·  John Sundy (2)  ·  4D pharma plc (1)  ·  Amgen (1)  ·  Arrowhead Pharmaceuticals (1)  ·  Asmacure Ltée (1)  ·  Atridia Pty Ltd. (1)  ·  Chiesi Farmaceutici S.p.A. (1)  ·  Emory University (1)  ·  Emphycorp (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Janssen Research & Development, LLC (1)  ·  Jasper Therapeutics, Inc. (1)

Countries

United States (16)  ·  United Kingdom (8)  ·  Canada (5)  ·  Australia (3)  ·  Germany (1)  ·  New Zealand (1)  ·  Panama (1)  ·  Poland (1)  ·  South Korea (1)  ·  Spain (1)  ·  Thailand (1)

Top investigators

Alessio Fasano, M. D. (1)  ·  Christopher Brightling, Professor (1)  ·  Christopher O'Brien, MD, PhD, FCCP (1)  ·  Dave Singh (1)  ·  David Kaminsky, MD (1)  ·  Donald Tashkin, M.D. (1)  ·  Dr Richard Friend (1)  ·  Edwin Horwitz, MD (1)  ·  Huaiyu Gu (1)  ·  Jim Shi, M.D., Ph.D. (1)  ·  John S Sundy, M.D., PhD (1)  ·  John S Sundy, M.D., PhD. (1)  ·  Juan P Wisnivesky, MD, DrPH (1)

Results publications

PMID 29550052, PMID 32150492, PMID 33314326, PMID 35128939

NIH funding

2015 (1), 2017 (1), P01AT002647 (1), R21AT004089 (1)